Correlation Between EFFECTOR Therapeutics and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both EFFECTOR Therapeutics and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EFFECTOR Therapeutics and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EFFECTOR Therapeutics and Roivant Sciences, you can compare the effects of market volatilities on EFFECTOR Therapeutics and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EFFECTOR Therapeutics with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of EFFECTOR Therapeutics and Roivant Sciences.
Diversification Opportunities for EFFECTOR Therapeutics and Roivant Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between EFFECTOR and Roivant is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding EFFECTOR Therapeutics and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and EFFECTOR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EFFECTOR Therapeutics are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of EFFECTOR Therapeutics i.e., EFFECTOR Therapeutics and Roivant Sciences go up and down completely randomly.
Pair Corralation between EFFECTOR Therapeutics and Roivant Sciences
Assuming the 90 days horizon EFFECTOR Therapeutics is expected to generate 19.2 times more return on investment than Roivant Sciences. However, EFFECTOR Therapeutics is 19.2 times more volatile than Roivant Sciences. It trades about 0.07 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.05 per unit of risk. If you would invest 12.00 in EFFECTOR Therapeutics on August 29, 2024 and sell it today you would lose (11.90) from holding EFFECTOR Therapeutics or give up 99.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 61.49% |
| Values | Daily Returns |
EFFECTOR Therapeutics vs. Roivant Sciences
Performance |
| Timeline |
| EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Roivant Sciences |
EFFECTOR Therapeutics and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with EFFECTOR Therapeutics and Roivant Sciences
The main advantage of trading using opposite EFFECTOR Therapeutics and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EFFECTOR Therapeutics position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
| Roivant Sciences vs. Krystal Biotech | Roivant Sciences vs. Akero Therapeutics | Roivant Sciences vs. Apellis Pharmaceuticals | Roivant Sciences vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |